アメリカの経口セファロスポリン市場

QYResearchが発行した調査報告書(QYR70506012)
◆英語タイトル:United States Oral Cephalosporin Market Report 2017
◆商品コード:QYR70506012
◆発行会社(リサーチ会社):QYResearch
◆発行日:2017年4月28日
◆ページ数:96

◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:アメリカ
◆産業分野:バイオ・医療・製薬
◆販売価格オプション(消費税別)
Single UserUSD3,800 ⇒換算¥421,800見積依頼/購入/質問フォーム
EnterpriseUSD7,600 ⇒換算¥843,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートでは、アメリカの経口セファロスポリン市場について調査・分析し、経口セファロスポリンのアメリカ市場概観、経口セファロスポリンの種類別市場分析、用途別市場分析、経口セファロスポリンのアメリカ市場規模予測、関連企業分析、関連企業情報、価格情報、販売動向、アメリカ市場動向、貿易動向、市場環境分析情報などを含め、以下の構成でお届けいたします。

・経口セファロスポリンのアメリカ市場概観
・経口セファロスポリンの種類別市場規模
・経口セファロスポリンの用途別市場規模
・経口セファロスポリンのアメリカ市場規模
・経口セファロスポリンのアメリカ市場予測
・経口セファロスポリンの製造メーカー分析
・経口セファロスポリンのメーカー別生産量
・経口セファロスポリンのメーカー別市場シェア
・経口セファロスポリンの価格動向・価格分析
・経口セファロスポリンの販売(売上高)動向
・経口セファロスポリンの貿易(輸出・輸入)動向
・経口セファロスポリンの産業チェーン分析
・経口セファロスポリンのマーケティング戦略分析
・経口セファロスポリンの販売業者(代理店)リスト
・経口セファロスポリンの市場環境分析
...
【レポートの概要】

In this report, the United States Oral Cephalosporin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Oral Cephalosporin in these regions, from 2012 to 2022 (forecast).

United States Oral Cephalosporin market competition by top manufacturers/players, with Oral Cephalosporin sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
GSK
Lupin Pharmaceuticals
Sanofi
Ankur Drugs and Pharma Ltd
SAKAR

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Cefotaxime Acid
Cephalexin
Amoxicillin
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Oral Cephalosporin for each application, including
Hospital
Clinic
Medical Center

If you have any special requirements, please let us know and we will offer you the report as you want.

【レポートの目次】

Table of Contents

United States Oral Cephalosporin Market Report 2017
1 Oral Cephalosporin Overview
1.1 Product Overview and Scope of Oral Cephalosporin
1.2 Classification of Oral Cephalosporin by Product Category
1.2.1 United States Oral Cephalosporin Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Oral Cephalosporin Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Cefotaxime Acid
1.2.4 Cephalexin
1.2.5 Amoxicillin
1.2.6 Others
1.3 United States Oral Cephalosporin Market by Application/End Users
1.3.1 United States Oral Cephalosporin Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Medical Center
1.4 United States Oral Cephalosporin Market by Region
1.4.1 United States Oral Cephalosporin Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Oral Cephalosporin Status and Prospect (2012-2022)
1.4.3 Southwest Oral Cephalosporin Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Oral Cephalosporin Status and Prospect (2012-2022)
1.4.5 New England Oral Cephalosporin Status and Prospect (2012-2022)
1.4.6 The South Oral Cephalosporin Status and Prospect (2012-2022)
1.4.7 The Midwest Oral Cephalosporin Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Oral Cephalosporin (2012-2022)
1.5.1 United States Oral Cephalosporin Sales and Growth Rate (2012-2022)
1.5.2 United States Oral Cephalosporin Revenue and Growth Rate (2012-2022)

2 United States Oral Cephalosporin Market Competition by Players/Suppliers
2.1 United States Oral Cephalosporin Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Oral Cephalosporin Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Oral Cephalosporin Average Price by Players/Suppliers (2012-2017)
2.4 United States Oral Cephalosporin Market Competitive Situation and Trends
2.4.1 United States Oral Cephalosporin Market Concentration Rate
2.4.2 United States Oral Cephalosporin Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Oral Cephalosporin Manufacturing Base Distribution, Sales Area, Product Type

3 United States Oral Cephalosporin Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Oral Cephalosporin Sales and Market Share by Region (2012-2017)
3.2 United States Oral Cephalosporin Revenue and Market Share by Region (2012-2017)
3.3 United States Oral Cephalosporin Price by Region (2012-2017)

4 United States Oral Cephalosporin Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Oral Cephalosporin Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Oral Cephalosporin Revenue and Market Share by Type (2012-2017)
4.3 United States Oral Cephalosporin Price by Type (2012-2017)
4.4 United States Oral Cephalosporin Sales Growth Rate by Type (2012-2017)

5 United States Oral Cephalosporin Sales (Volume) by Application (2012-2017)
5.1 United States Oral Cephalosporin Sales and Market Share by Application (2012-2017)
5.2 United States Oral Cephalosporin Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Oral Cephalosporin Players/Suppliers Profiles and Sales Data
6.1 GSK
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Oral Cephalosporin Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 GSK Oral Cephalosporin Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Lupin Pharmaceuticals
6.2.2 Oral Cephalosporin Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Lupin Pharmaceuticals Oral Cephalosporin Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Sanofi
6.3.2 Oral Cephalosporin Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Sanofi Oral Cephalosporin Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Ankur Drugs and Pharma Ltd
6.4.2 Oral Cephalosporin Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Ankur Drugs and Pharma Ltd Oral Cephalosporin Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 SAKAR
6.5.2 Oral Cephalosporin Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 SAKAR Oral Cephalosporin Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview

7 Oral Cephalosporin Manufacturing Cost Analysis
7.1 Oral Cephalosporin Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Oral Cephalosporin

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Oral Cephalosporin Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Oral Cephalosporin Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Oral Cephalosporin Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Oral Cephalosporin Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Oral Cephalosporin Sales Volume Forecast by Type (2017-2022)
11.3 United States Oral Cephalosporin Sales Volume Forecast by Application (2017-2022)
11.4 United States Oral Cephalosporin Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Oral Cephalosporin
Figure United States Oral Cephalosporin Market Size (K Pcs) by Type (2012-2022)
Figure United States Oral Cephalosporin Sales Volume Market Share by Type (Product Category) in 2016
Figure Cefotaxime Acid Product Picture
Figure Cephalexin Product Picture
Figure Amoxicillin Product Picture
Figure Others Product Picture
Figure United States Oral Cephalosporin Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Oral Cephalosporin by Application in 2016
Figure Hospital Examples
Figure Clinic Examples
Figure Medical Center Examples
Figure United States Oral Cephalosporin Market Size (Million USD) by Region (2012-2022)
Figure The West Oral Cephalosporin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Oral Cephalosporin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Oral Cephalosporin Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Oral Cephalosporin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Oral Cephalosporin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Oral Cephalosporin Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Oral Cephalosporin Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Oral Cephalosporin Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Oral Cephalosporin Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Oral Cephalosporin Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Oral Cephalosporin Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Oral Cephalosporin Sales Share by Players/Suppliers
Figure 2017 United States Oral Cephalosporin Sales Share by Players/Suppliers
Figure United States Oral Cephalosporin Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Oral Cephalosporin Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Oral Cephalosporin Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Oral Cephalosporin Revenue Share by Players/Suppliers
Figure 2017 United States Oral Cephalosporin Revenue Share by Players/Suppliers
Table United States Market Oral Cephalosporin Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Oral Cephalosporin Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Oral Cephalosporin Market Share of Top 3 Players/Suppliers
Figure United States Oral Cephalosporin Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Oral Cephalosporin Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Oral Cephalosporin Product Category
Table United States Oral Cephalosporin Sales (K Pcs) by Region (2012-2017)
Table United States Oral Cephalosporin Sales Share by Region (2012-2017)
Figure United States Oral Cephalosporin Sales Share by Region (2012-2017)
Figure United States Oral Cephalosporin Sales Market Share by Region in 2016
Table United States Oral Cephalosporin Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Oral Cephalosporin Revenue Share by Region (2012-2017)
Figure United States Oral Cephalosporin Revenue Market Share by Region (2012-2017)
Figure United States Oral Cephalosporin Revenue Market Share by Region in 2016
Table United States Oral Cephalosporin Price (USD/Pcs) by Region (2012-2017)
Table United States Oral Cephalosporin Sales (K Pcs) by Type (2012-2017)
Table United States Oral Cephalosporin Sales Share by Type (2012-2017)
Figure United States Oral Cephalosporin Sales Share by Type (2012-2017)
Figure United States Oral Cephalosporin Sales Market Share by Type in 2016
Table United States Oral Cephalosporin Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Oral Cephalosporin Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oral Cephalosporin by Type (2012-2017)
Figure Revenue Market Share of Oral Cephalosporin by Type in 2016
Table United States Oral Cephalosporin Price (USD/Pcs) by Types (2012-2017)
Figure United States Oral Cephalosporin Sales Growth Rate by Type (2012-2017)
Table United States Oral Cephalosporin Sales (K Pcs) by Application (2012-2017)
Table United States Oral Cephalosporin Sales Market Share by Application (2012-2017)
Figure United States Oral Cephalosporin Sales Market Share by Application (2012-2017)
Figure United States Oral Cephalosporin Sales Market Share by Application in 2016
Table United States Oral Cephalosporin Sales Growth Rate by Application (2012-2017)
Figure United States Oral Cephalosporin Sales Growth Rate by Application (2012-2017)
Table GSK Basic Information List
Table GSK Oral Cephalosporin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GSK Oral Cephalosporin Sales Growth Rate (2012-2017)
Figure GSK Oral Cephalosporin Sales Market Share in United States (2012-2017)
Figure GSK Oral Cephalosporin Revenue Market Share in United States (2012-2017)
Table Lupin Pharmaceuticals Basic Information List
Table Lupin Pharmaceuticals Oral Cephalosporin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Lupin Pharmaceuticals Oral Cephalosporin Sales Growth Rate (2012-2017)
Figure Lupin Pharmaceuticals Oral Cephalosporin Sales Market Share in United States (2012-2017)
Figure Lupin Pharmaceuticals Oral Cephalosporin Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Oral Cephalosporin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi Oral Cephalosporin Sales Growth Rate (2012-2017)
Figure Sanofi Oral Cephalosporin Sales Market Share in United States (2012-2017)
Figure Sanofi Oral Cephalosporin Revenue Market Share in United States (2012-2017)
Table Ankur Drugs and Pharma Ltd Basic Information List
Table Ankur Drugs and Pharma Ltd Oral Cephalosporin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Ankur Drugs and Pharma Ltd Oral Cephalosporin Sales Growth Rate (2012-2017)
Figure Ankur Drugs and Pharma Ltd Oral Cephalosporin Sales Market Share in United States (2012-2017)
Figure Ankur Drugs and Pharma Ltd Oral Cephalosporin Revenue Market Share in United States (2012-2017)
Table SAKAR Basic Information List
Table SAKAR Oral Cephalosporin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure SAKAR Oral Cephalosporin Sales Growth Rate (2012-2017)
Figure SAKAR Oral Cephalosporin Sales Market Share in United States (2012-2017)
Figure SAKAR Oral Cephalosporin Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oral Cephalosporin
Figure Manufacturing Process Analysis of Oral Cephalosporin
Figure Oral Cephalosporin Industrial Chain Analysis
Table Raw Materials Sources of Oral Cephalosporin Major Players/Suppliers in 2016
Table Major Buyers of Oral Cephalosporin
Table Distributors/Traders List
Figure United States Oral Cephalosporin Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Oral Cephalosporin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Oral Cephalosporin Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Oral Cephalosporin Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Oral Cephalosporin Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Oral Cephalosporin Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Oral Cephalosporin Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Oral Cephalosporin Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Oral Cephalosporin Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Oral Cephalosporin Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Oral Cephalosporin Sales Volume Share Forecast by Region (2017-2022)
Figure United States Oral Cephalosporin Sales Volume Share Forecast by Region (2017-2022)
Figure United States Oral Cephalosporin Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ アメリカの経口セファロスポリン市場(United States Oral Cephalosporin Market Report 2017)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆